Prostate Cancer: The role of inflammation and chemokines

Rani, A., Dasgupta, P. and Murphy, J.J. 2019. Prostate Cancer: The role of inflammation and chemokines. American Journal of Pathology. 189 (11), pp. 2119-2137. https://doi.org/10.1016/j.ajpath.2019.07.007

TitleProstate Cancer: The role of inflammation and chemokines
TypeJournal article
AuthorsRani, A., Dasgupta, P. and Murphy, J.J.
Abstract

Prostate cancer (PC) is a leading cause of death in men. Inflammation is one of the initiating processeswhereby cells are trafficked into the tumor microenvironment by specific cytokines termed chemokines. Thisrecruitment is complex and involves diverse leukocyte subsets with procancer and anticancer functions.Chemokines promote/abrogate proliferation of cancerous cells, block/aid apoptosis, and are instrumental/detrimental in cancer cell migration required for metastasis. Chemokines guide the release/transport ofimmune cells that serve aschaperones at sites of inflammation, and after subsequent activation, theylead toan immune response. The variety of immune cells recruited at the site of tumor initiation possess uniquefunctions, and the plethora of chemokines released by each cell derived from a progenitor cell activatedunder a defined set of conditions dictates its specific role in cancer progression/regression. Geographicconsequences that govern the climate and endemic diseases, along with the associated evolutionaryeffects that at times protect populations from one disease, could lead to genetic variations that determine arole for ethnicity and race in PC risk and susceptibility. Dysregulated expression or an imbalance in thehomeostatic mechanisms associated with chemokines is implicated in PC. This review discusses the role of inflammation and chemokines in PC.

Keywordschemokines
prostate cancer
JournalAmerican Journal of Pathology
Journal citation189 (11), pp. 2119-2137
ISSN0002-9440
Year2019
PublisherElsevier
Digital Object Identifier (DOI)https://doi.org/10.1016/j.ajpath.2019.07.007
Publication dates
Published11 Nov 2019

Related outputs

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
Rani, A., Stebbing, J., Giamas, G. and Murphy, J.J. 2019. Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy. Frontiers in Endocrinology. 10 245. https://doi.org/10.3389/fendo.2019.00245

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer
Ribas, R., Pancholi, S., Rani, A., Schuster, E., Guest, S., Nikitorowicz-Buniak, J., Simigdala, N., Thornhill, A., Avogadri-Connors, F., Cutler, R., Lalani, A., Dowsett, M., Johnston, S. and Martin, L. 2018. Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer. Breast Cancer Research. 20, p. 44 44. https://doi.org/10.1186/S13058-018-0983-1

PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers
Coffey, G., Rani, A., Betz, A., Pak, Y., Haberstock-Debic, H., Pandey, A., Hollenbach, S., Gretler, D.D., Mant, T., Jurcevic, S. and Sinha, U. 2017. PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers. Journal of Clinical Pharmacology . 57 (2), p. 194–210. https://doi.org/10.1002/jcph.794

HES1 in immunity and cancer
Rani, A., Greenlaw, R., Smith, R.A. and Galustian, C. 2016. HES1 in immunity and cancer. Cytokine & Growth Factor Reviews. 30, pp. 113-117. https://doi.org/10.1016/j.cytogfr.2016.03.010

STAT5 in Cancer and Immunity
Murphy, J.J. and Rani, A. 2016. STAT5 in Cancer and Immunity. Journal of Interferon & Cytokine Research. 36 (4), pp. 226-237. https://doi.org/10.1089/jir.2015.0054

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer
López-Knowles, E., Wilkerson, P., Ribas, R., Anderson, H., Mackay, A., Ghazoui, Z., Rani, A., Osin, P., Nerurkar, A., Renshaw, L., Larionov, A., Miller, W., Dixon, J., Reis-Filho, J., Dunbier, A., Martin, L. and Dowsett, M. 2015. Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer. Breast Cancer Research. 17, p. 35 35. https://doi.org/10.1186/S13058-015-0532-0

Evidence for targeting of CD38 mRNA by the post-transcriptional regulator protein ZFP36L1
Murphy, J.J. 2015. Evidence for targeting of CD38 mRNA by the post-transcriptional regulator protein ZFP36L1. 4th European Congress of Immunology. Vienna 08 Sep 2015

The Notch target Hes1, is a STAT5 target gene with implications in cancer
Rani, A., Greenlaw, R., Galustian, C. and Murphy, J.J. 2015. The Notch target Hes1, is a STAT5 target gene with implications in cancer. 2015 Meeting of the ICIS in Bamberg, Germany, October 11th -14th. Bamberg, Germany Oct 2015 https://doi.org/10.1016/j.cyto.2015.08.214

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
Ribas, R., Ghazoui, Z., Gao, Q., Pancholi, S., Rani, A., Dunbier, A., Dowsett, M. and Martin, L. 2014. Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers. Breast Cancer Research. 16, p. 447 447. https://doi.org/10.1186/s13058-014-0447-1

Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells
Zekavati, A., Nasir, A., Alcaraz, A., Aldrovandi, M., Marsh, P., Norton, J.D. and Murphy, J.J. 2014. Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells. PLoS ONE. 9 (7) e102625. https://doi.org/10.1371/journal.pone.0102625

ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA
Nasir, A., Norton, J.D., Baou, M., Zekavati, A., Bijlmakers, M.J., Thompson, S. and Murphy, J.J. 2012. ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. PLoS ONE. 7 (12) e52187. https://doi.org/10.1371/journal.pone.0052187

AU-rich RNA binding proteins in hematopoiesis and leukemogenesis
Baou, M., Norton, J.D. and Murphy, J.J. 2011. AU-rich RNA binding proteins in hematopoiesis and leukemogenesis. Blood. 118 (22), pp. 5732-5740. https://doi.org/10.1182/blood-2011-07-347237

IL-2 Regulates Expression of C-MAF in Human CD4 T Cells
Rani, A., Afzali, B., Kelly, A., Tewolde-Berhan, L., Hacket, M., Kanhere, A., Pedroza-Pacheco, I., Bowen, H., Jurcevic, S., Jenner, R., Cousins, D., Ragheb, J., Lavender, P. and John, S. 2011. IL-2 Regulates Expression of C-MAF in Human CD4 T Cells. Journal of Immunology. 187 (7), pp. 3721-3729. https://doi.org/10.4049/jimmunol.1002354

Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells
Baou, M., Jewell, A.P., Muthurania, A., Wickremasinghe, R.G., Yong, K.L., Carr, R., Marsh, P. and Murphy, J.J. 2009. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia. 23 (5), pp. 986-989. https://doi.org/10.1038/leu.2008.340

Post-transcriptional regulator protein ZFP36L1 targeting of Bcl-2 mRNA
Zekavati, A., Marsh, P. and Murphy, J.J. 2009. Post-transcriptional regulator protein ZFP36L1 targeting of Bcl-2 mRNA. 2nd European Congress of Immunology. Berlin, Germany 13 – 16 September 2009

Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line
Nasir, A., Roberts, H., Thompson, S. and Murphy, J.J. 2009. Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line. 2nd European Congress of Immunology. Berlin, Germany 13 – 16 September 2009

TIS11 family proteins and their roles in post-transcriptional gene regulation
Baou, M., Jewell, A.P. and Murphy, J.J. 2009. TIS11 family proteins and their roles in post-transcriptional gene regulation. Journal of Biomedicine and Biotechnology. 634520. https://doi.org/10.1155/2009/634520

Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line
Nasir, A., Roberts, H., Thompson, S. and Murphy, J.J. 2008. Evidence for involvement of ZFP36L1 protein downregulation in differentiation of the murine BCL1 leukaemia cell line. BSI Immunology Congress. Glasgow 17-21 November 2008

Mode of action of Rituximab in chronic lymphocytic leukaemia: activation of Tis11b, an inducer of mRNA instability and induction of apoptosis
Baou, M., Jewell, A.P., Yong, K.L. and Murphy, J.J. 2008. Mode of action of Rituximab in chronic lymphocytic leukaemia: activation of Tis11b, an inducer of mRNA instability and induction of apoptosis. in: Moreau, I.B. (ed.) Chronic lymphocytic leukemia: new research Nova Science Publishers. pp. 141-155

Permalink - https://westminsterresearch.westminster.ac.uk/item/qyv45/prostate-cancer-the-role-of-inflammation-and-chemokines


Share this
Tweet
Email

Usage statistics

13 total views
1 total downloads
0 views this month
0 downloads this month
These values are for the period from September 2nd 2018, when this repository was created

Export as